BioNexus Gene Lab EBIT 2019-2024 | BGLC

BioNexus Gene Lab ebit from 2019 to 2024. Ebit can be defined as earnings before interest and taxes.

BioNexus Gene Lab EBIT 2019-2024 | BGLC

BioNexus Gene Lab ebit from 2019 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$120.6B
Cencora (COR)$44.1B
ICON (ICLR)$23.6B
DiDi Global (DIDIY)$22.4B
Avantor (AVTR)$17.7B
Revvity (RVTY)$15.6B
Natera (NTRA)$15.3B
Viatris (VTRS)$13.9B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$11.8B
Charles River Laboratories (CRL)$10.2B
Medpace Holdings (MEDP)$10.1B
Sonic Healthcare (SKHHY)$9.1B
Doximity (DOCS)$7.9B
HealthEquity (HQY)$6.9B
Bausch + Lomb (BLCO)$6.7B
PACS (PACS)$6B
Organon (OGN)$4.9B
Life Times (LTH)$4.9B
Sotera Health (SHC)$4.7B
Surgery Partners (SGRY)$4.1B
Concentras Parent (CON)$2.9B
Ardent Health Partners (ARDT)$2.7B
GoodRx Holdings (GDRX)$2.5B
BrightSpring Health Services (BTSG)$2.5B
Alignment Healthcare (ALHC)$2.1B
Premier (PINC)$2B
Ryman Healthcare (RYHTY)$2B
AMN Healthcare Services Inc (AMN)$1.6B
CareDx (CDNA)$1.6B